MX2013005009A - Metodo para la elaboracion de naltrexona. - Google Patents

Metodo para la elaboracion de naltrexona.

Info

Publication number
MX2013005009A
MX2013005009A MX2013005009A MX2013005009A MX2013005009A MX 2013005009 A MX2013005009 A MX 2013005009A MX 2013005009 A MX2013005009 A MX 2013005009A MX 2013005009 A MX2013005009 A MX 2013005009A MX 2013005009 A MX2013005009 A MX 2013005009A
Authority
MX
Mexico
Prior art keywords
naltrexone
manufacturing
dihydroxy
epoxy
cyclopropylmethyl
Prior art date
Application number
MX2013005009A
Other languages
English (en)
Spanish (es)
Inventor
Florian Anton Martin Huber
Carla De Faveri
Mariano Stivanello
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MX2013005009A publication Critical patent/MX2013005009A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2013005009A 2010-11-05 2011-11-04 Metodo para la elaboracion de naltrexona. MX2013005009A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41040510P 2010-11-05 2010-11-05
DKPA201001007 2010-11-05
US201161489701P 2011-05-25 2011-05-25
DKPA201100396 2011-05-25
PCT/DK2011/000128 WO2012059103A1 (en) 2010-11-05 2011-11-04 Method for the manufacturing of naltrexone

Publications (1)

Publication Number Publication Date
MX2013005009A true MX2013005009A (es) 2013-08-01

Family

ID=45001588

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013005009A MX2013005009A (es) 2010-11-05 2011-11-04 Metodo para la elaboracion de naltrexona.

Country Status (20)

Country Link
EP (1) EP2635586B1 (https=)
JP (2) JP6246589B2 (https=)
AP (1) AP3415A (https=)
AU (1) AU2011325563B2 (https=)
CA (1) CA2815093C (https=)
CY (1) CY1118742T1 (https=)
DK (1) DK2635586T3 (https=)
EA (1) EA022266B1 (https=)
ES (1) ES2620660T3 (https=)
HR (1) HRP20170379T1 (https=)
HU (1) HUE033596T2 (https=)
LT (1) LT2635586T (https=)
ME (1) ME02621B (https=)
MX (1) MX2013005009A (https=)
PL (1) PL2635586T3 (https=)
PT (1) PT2635586T (https=)
RS (1) RS55777B1 (https=)
SI (1) SI2635586T1 (https=)
SM (1) SMT201700177T1 (https=)
WO (1) WO2012059103A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
MX368870B (es) 2013-12-20 2019-10-21 H Lundbeck As Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas.
EP3134090B1 (en) 2014-04-22 2019-06-05 Otsuka Pharmaceutical Co., Ltd. Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
US9701688B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds
US9701687B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
CA2067200C (en) * 1989-10-16 1998-06-30 Kenner C. Rice Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
FR2906252B1 (fr) * 2006-09-21 2008-11-28 Sanofi Aventis Sa Procede de preparation d'halogenures de n-aklyl naltrexone
WO2008138383A1 (de) * 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
CA2738246C (en) * 2008-09-30 2017-09-05 Mallinckrodt Inc. Processes for the alkylation of secondary amine groups of morphinan derivatives
ES2564006T3 (es) 2009-05-25 2016-03-17 H. Lundbeck A/S Preparación de hidrocloruro de nalmefeno a partir de naltrexona

Also Published As

Publication number Publication date
JP2016199566A (ja) 2016-12-01
PL2635586T3 (pl) 2017-06-30
EP2635586A1 (en) 2013-09-11
SMT201700177T1 (it) 2017-05-08
EA022266B1 (ru) 2015-11-30
CY1118742T1 (el) 2017-07-12
JP6246589B2 (ja) 2017-12-13
JP6215399B2 (ja) 2017-10-18
RS55777B1 (sr) 2017-07-31
ME02621B (me) 2017-06-20
AU2011325563B2 (en) 2015-08-20
ES2620660T3 (es) 2017-06-29
CA2815093A1 (en) 2012-05-10
CA2815093C (en) 2019-08-06
LT2635586T (lt) 2017-04-10
HRP20170379T1 (hr) 2017-05-05
AU2011325563A1 (en) 2013-05-02
EA201390658A1 (ru) 2013-11-29
AP2013006897A0 (en) 2013-05-31
PT2635586T (pt) 2017-03-30
JP2013541564A (ja) 2013-11-14
DK2635586T3 (en) 2017-03-27
WO2012059103A1 (en) 2012-05-10
HUE033596T2 (hu) 2017-12-28
SI2635586T1 (sl) 2017-07-31
AP3415A (en) 2015-09-30
EP2635586B1 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
MX2015016535A (es) Metodo de produccion para tagatosa.
EP2845867A4 (en) METHOD FOR THE PRODUCTION OF CONJUGATED SERVICE RUBBER
EP2397459A4 (en) METHOD FOR PRODUCING A PHENYLACETAMIDE COMPOUND
MX2013005009A (es) Metodo para la elaboracion de naltrexona.
BR112014019909A8 (pt) Processo para produção de compostos úteis como antagonistas do receptor de orexina-2
CO7220321A2 (es) Método para producir un aditivo así como carbonato de calcio a partir de agregado de concreto así como un dispositivo para realizar el procedimiento
BR112012029925A2 (pt) pedra-pomes granulada, bem como processo para produção de pedra-pomes granulada
IL236523B (en) Methods for producing antibody molecules with intra-target cross-sexual reactivity
EP2708521A4 (en) METHOD FOR PRODUCING A CONDUCTIVE MAYENITE COMPOUND
EP2608249A4 (en) METHOD FOR PRODUCING A TRANSISTOR
BR112018077067A2 (pt) processo para preparar um composto.
EP2554887A4 (en) FUEL HOSE AND MANUFACTURING METHOD THEREFOR
EP2610250A4 (en) METHOD FOR PRODUCING A METHYLENE SULFONATE COMPOUND
FR3012137B1 (fr) Procede de production de composes fluores
BR112013027976A2 (pt) processos e intermediários na preparação de análogos de morfina através da n-desmetilação dos n-óxidos utilizando os reagentes de ciclodesidratação
EP2557108A4 (en) METHOD FOR PRODUCING AN ORGANOPOLYSILOXAN COMPOUND
EP2990467A4 (en) Method for producing molded solid fuel
MX2015015151A (es) Metodo para producir 4-hidroxi-4-metil-tetrahidropiranos 2-sustituidos, donde dicho proceso usa reciclado.
EP2878590A4 (en) PROCESS FOR PREPARING KRESOL BY PHENOL-METHANOL GAS PHASE ALKYLATION
EP2703386A4 (en) METHOD FOR PRODUCING A DIAMIN COMPOUND
ZA201505324B (en) Method of synthesising amino acid by metathesis, hydrolysis, then hydrogenation
BR112012020855A2 (pt) Método para produzir um conjugado de biomolécula
MX354331B (es) Proceso de recuperación de clorhidrato de nalmefeno.
MX337997B (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
EP2719681A4 (en) METHOD FOR PRODUCING A CYCLOPENTANONE COMPOUND AND INTERMEDIATE PRODUCT THEREOF

Legal Events

Date Code Title Description
FG Grant or registration